SIRT2 and neoplasm: In animal models, SIRT2 inhibition resulted in decreased oncogenic markers and an increase in neuronal differentiation markers, suggesting that targeting SIRT2 may promote differentiation in ATRT cells, potentially leading to less aggressive tumor behavior [77].